Financial Summary for the First Quarter of Fiscal Year Ending September 2026 [Japanese GAAP] (Consolidated)

Overview of Operating Results

For the first quarter of the fiscal year ending September 2026 (October 1, 2025 to December 31, 2025), consolidated financial results were net sales of 15,466 million yen (7.9% decrease YoY), operating income of 2,251 million yen (29.0% decrease YoY), ordinary income of 2,417 million yen (26.2% decrease YoY), and net income attributable to owners of parent for the quarter of 1,321 million yen (35.7% increase YoY). The cosmetics segment reported net sales of 12,279 million yen (9.4% decrease YoY) and segment profit of 2,525 million yen (28.6% decrease YoY). The pharmaceutical and food segment recorded net sales of 2,878 million yen (2.5% decrease YoY) and segment profit of 372 million yen (49.9% increase YoY). The other segments posted net sales of 308 million yen (2.7% increase YoY) and segment profit of 10 million yen (10.3% increase YoY).

Overview of Financial Position and Earnings Guidance

At the end of the first quarter of the fiscal year ending September 2026, total assets stood at 70,427 million yen, net assets at 48,022 million yen, and the equity ratio at 67.4%. The full-year consolidated earnings forecast projects net sales of 65,000 million yen (0.4% increase YoY), operating income of 11,400 million yen (2.9% increase YoY), ordinary income of 11,800 million yen (0.2% increase YoY), net income attributable to owners of parent of 8,200 million yen (2.1% increase YoY), and earnings per share of 240.07 yen. There is no revision from the latest earnings forecast.